Market closedNon-fractional

Adicet Bio/ACET

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Adicet Bio

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Ticker

ACET

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Boston, United States

Employees

143

Adicet Bio Metrics

BasicAdvanced
$88M
Market cap
-
P/E ratio
-$2.68
EPS
1.76
Beta
-
Dividend rate
$88M
1.76
14.338
14.18
6.458
7.742
-16,265.63%
-27.20%
-53.25%
0.34
0.34
-0.585
6.74%
-12.65%

What the Analysts think about Adicet Bio

Analyst Ratings

Majority rating from 9 analysts.
Buy

Adicet Bio Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$28M
-4.76%
Profit margin
0.00%
NaN%

Adicet Bio Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.75%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.75
-$1.16
-$0.69
-$0.35
-
Expected
-$0.68
-$0.74
-$0.69
-$0.39
-$0.37
Surprise
10.04%
57.33%
-0.65%
-9.75%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Adicet Bio stock?

Adicet Bio (ACET) has a market cap of $88M as of July 06, 2024.

What is the P/E ratio for Adicet Bio stock?

The price to earnings (P/E) ratio for Adicet Bio (ACET) stock is 0 as of July 06, 2024.

Does Adicet Bio stock pay dividends?

No, Adicet Bio (ACET) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Adicet Bio dividend payment date?

Adicet Bio (ACET) stock does not pay dividends to its shareholders.

What is the beta indicator for Adicet Bio?

Adicet Bio (ACET) has a beta rating of 1.76. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Adicet Bio stock

Buy or sell Adicet Bio stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing